GOODWILL(SH:688246)2023-10-27 16:00Financial Performance - The company's operating revenue for Q3 2023 was ¥245,755,766.88, representing a year-on-year increase of 20.82%[5] - The net profit attributable to shareholders for Q3 2023 was ¥41,194,041.14, reflecting a significant increase of 50.95% compared to the same period last year[6] - The net profit attributable to shareholders, excluding non-recurring gains and losses, was ¥40,416,708.49, up 52.63% year-on-year[6] - The basic earnings per share for Q3 2023 was ¥0.30, an increase of 50.00% compared to the same period last year[6] - Total revenue for the first three quarters of 2023 reached ¥537,712,968.92, compared to ¥455,321,747.12 in the same period of 2022, representing an increase of approximately 18.1%[21] - Net profit for Q3 2023 was ¥1,117,873.06, a significant improvement from a net loss of ¥18,939,625.90 in Q3 2022[22] - Total comprehensive income for the third quarter amounted to CNY 1,117,873.06, a decrease of 18,939,625.90 compared to the previous period[23] Research and Development - The total R&D investment for Q3 2023 was ¥57,220,973.67, which accounted for 23.28% of the operating revenue, an increase of 1.01 percentage points year-on-year[6] - Research and development expenses for the first three quarters of 2023 were ¥127,290,711.34, compared to ¥135,334,064.77 in the same period of 2022, indicating a decrease of approximately 6.0%[21] Assets and Liabilities - The total assets at the end of Q3 2023 were ¥2,461,186,628.11, a decrease of 2.61% compared to the end of the previous year[6] - The company's total assets as of Q3 2023 were ¥2,461,186,628.11, a decrease from ¥2,527,045,461.81 in the previous year[20] - Total liabilities decreased to ¥610,456,442.96 in Q3 2023 from ¥683,425,530.94 in Q3 2022, reflecting a reduction of approximately 10.7%[19] - The company's cash and cash equivalents showed a decline, with total current assets at ¥2,070,333,698.01 compared to ¥2,260,656,635.23 in the previous year, a decrease of about 8.4%[20] Cash Flow - The cash flow from operating activities for Q3 2023 was negative at -¥30,823,444.92, indicating a significant cash outflow[6] - Cash inflow from operating activities for the first three quarters was CNY 406,557,142.52, slightly up from CNY 401,685,600.36 in the same period last year[25] - Net cash flow from operating activities was negative CNY 226,519,885.58, an improvement from negative CNY 288,844,282.25 year-over-year[25] - Cash outflow for investing activities totaled CNY 140,009,333.36, compared to CNY 110,972,257.29 in the previous year[27] - Net cash flow from investing activities was negative CNY 29,373,265.20, an improvement from negative CNY 107,819,577.63 year-over-year[27] - Cash inflow from financing activities was CNY 80,699,204.04, significantly higher than CNY 28,578,000.00 in the previous year[27] - Net cash flow from financing activities was negative CNY 54,693,186.32, an improvement from negative CNY 156,908,225.29 year-over-year[27] - The ending balance of cash and cash equivalents was CNY 382,650,059.49, down from CNY 555,579,181.95 in the previous year[27] Shareholder Information - Total number of common shareholders at the end of the reporting period is 5,617[13] - The largest shareholder, Xia Jun, holds 24,750,839 shares, representing 17.88% of total shares[13] - The second largest shareholder, Guo Shou Cheng Da (Shanghai) Health Industry Equity Investment Center, holds 16,812,069 shares, representing 12.14%[13] - The top ten shareholders include various investment funds, with the largest being the Guo Shou Cheng Da (Shanghai) Health Industry Equity Investment Center[14] Strategic Developments - The company has not disclosed any significant new product developments or market expansion strategies in the current report[16] - There is no indication of any mergers or acquisitions in the recent financial disclosures[16] - The company has not provided specific future performance guidance in the current report[16] Other Financial Metrics - The weighted average return on equity for Q3 2023 was 2.27%, an increase of 0.69 percentage points year-on-year[6] - Total cash and cash equivalents as of September 30, 2023, is ¥439,282,235.82, down from ¥851,754,652.56 as of December 31, 2022[17] - Accounts receivable increased to ¥474,072,329.40 from ¥407,388,910.73 year-over-year[17] - The company has trading financial assets amounting to ¥30,000,000.00[17] - The company has made significant investments in long-term equity investments, totaling ¥3,500,000.00 as of Q3 2023, indicating a strategic focus on long-term growth[20] - The total equity attributable to shareholders increased to ¥1,833,314,454.86 in Q3 2023 from ¥1,810,796,740.66 in Q3 2022, reflecting a growth of approximately 1.2%[20]